On 1 August 2024, Bumrungrad International Hospital marked a significant milestone in its commitment to advanced healthcare by hosting a press conference, ‘Bumrungrad: Pioneering the Genomics Frontier,’ to celebrate its certification as a Genomic Medicine Provider by the Ministry of Public Health. This certification distinguishes Bumrungrad as a leader in genomic medicine in Thailand, emphasizing its role in leveraging cutting-edge genetic technologies to enhance patient care.
Artirat Charukitpipat, Ph.D., CEO of Bumrungrad International Hospital, delivered a welcome speech that emphasized the hospital’s commitment to leveraging its academic excellence to enhance medical practices. The newly certified Bumrungrad Genomic Medicine Center was showcased as Thailand’s sole comprehensive provider of preventive genomic healthcare, utilizing cutting-edge genetic technologies for disease prevention and treatment.
Key speakers during the panel discussion, including Dr. Chanin Limwongse, a specialist in Genomic Medicine at Bumrungrad International Hospital and Prof. Dr. Chonlaphat Sukasem, Pharmacogenetics Consultant at Bumrungrad International Hospital discussed the impact of personalized care and genetic testing in treating complex diseases and enhancing drug efficacy and safety. Asst. Prof. Dr. Polakit Teekakirikul, Chief Scientific Officer at Bumrungrad International Hospital highlighted ongoing research and the use of artificial intelligence to improve diagnostic and treatment accuracy.
This event not only marked a milestone for Bumrungrad International Hospital but also set a new standard for healthcare excellence globally, reinforcing the hospital’s position as a leader in the field of genomic medicine.
Click here for a highlight video